AzTrials
AzTrials

COPDNCT05335265

A Comparison of Classic and Virtual Inhaler Training Methods in COPD Patients

A study testing Treatment training in people with COPD and Inhaler Training, run by Ayse Baha at 9 sites in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

According to the World Health Organization data, the third most common cause of death in the world, is COPD , a disease that progresses with exacerbations (1). Exacerbations are the most important cause of morbidity and mortality in COPD (2). Read more about this study

Who is it for?
Ages 40 to 65 years
Conditions the study is for
COPD, Inhaler Training, Face-to-face Training
What is being tested?
Treatment training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
102 participants
Where
9 sitesTurkey (Türkiye)
Study dates
1 Oct 2021to 31 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients who have not used MDI for at least 1 year.
  • Having COPD diagnosed with PFT (FEV1/FVC <70 in PFT in the last 1 year)
  • Being hospitalized with a COPD exacerbation and being discharged
  • Not having a hearing loss, mental disability, visual impairment and a physical impairment that would prevent the use of MDI
  • To have the necessary technological equipment to establish video communication on the phone
  • Who have agreed to participate in the study.

Who cannot join

  • Patients who have used MDI or have training MDI for at least 1 year.
  • Having a hearing loss, mental disability, visual impairment and a physical impairment that would prevent the use of MDI
  • Have not the necessary technological equipment to establish video communication on the phone

Trial locations and contacts

9 sites in 1 country.

9 sites in 1 country

Turkey (Türkiye)9 sites
  • Ankara City Hospital

    Ankara

  • Gazi University Faculty of Medicine

    Ankara

  • Ufuk University Faculty of Medicine

    Ankara

  • Muratpasa District Health Directorate

    Antalya

  • Balıkesir State Hospital

    Balıkesir

  • Dokuz Eylul University, Faculty of Medicine

    Izmir

  • Kütahya University of Health Sciences

    Kütahya

  • Celal Bayar University Faculty of Medicine

    Manisa

  • Near East University Faculty of Medicine

    Mersin-10, 99138

Other trials in Turkey (Türkiye)

About this study

Official title: Is Virtual Inhaler Training Successful in COPD?

According to the World Health Organization data, the third most common cause of death in the world, is COPD , a disease that progresses with exacerbations (1). Exacerbations are the most important cause of morbidity and mortality in COPD (2). It is thought that most exacerbations occur (3,4) because highly effective inhaler treatments are unavailable to prevent and treat respiratory symptoms (5,6). However, using inhaler devices correctly can be difficult (jama7,8). Guidelines recommend evaluating and teaching inhaler use technique (5,6). Unfortunately, these are often not implemented, especially in a hospital setting (9,10). Worldwide, 25 billion dollars are spent annually on inhaler drugs, 5-7 billion dollars of which is estimated to be wasted because of incorrect technique. Beyond this financial cost, incorrect inhaler technique is associated with worse symptom control, lower quality of life and increased acute care costs, (11,12,13). Although these shortcomings are known, appropriate educational interventions are unfortunately not been available.

Additionally , patient's access to health services (especially face-to-face communication with recommended health providers) has been largely prevented due to the restrictions/requirements implemented against the pandemic in 2020,such as social isolation, staying away from public environments, and ensuring good personal and social hygiene.

Considering that inhaler training is done face-to-face by doctors or allied health personnel today, many patients did not receive inhaler drug use training. One of the most realistic solutions that we encountered with this pandemic is telemedicine. The use of internet-mediated training, which is a part of telemedicine, has come to the foreground. In a recently published study on chronic airway diseases (asthma and COPD), it was revealed that video-mediated inhaler training is as successful as classical face-to-face training (14).Our aim is to investigate whether video-mediated virtual inhaler training is successful in patients with COPD.

Read the detailed description

Our aim is to investigate whether video-mediated virtual inhaler training is successful in patients with COPD

METHOD OF WORKING

Patients hospitalized due to COPD exacerbation and are ready to be discharged from the hospital will be included in this multicenter, prospective, randomized controlled study. Patients will be randomized according to a simple random numbers table, half of the patients will receive video-mediated virtual inhaler training (which is published on the Turkish Thoracic Society's official site and with permission for use obtained) and the other half will receive the same method as classical facial inhaler training videos.

Depending on the medical condition of the patients admitted to the ward, training will be implemented from the 24th hour of their hospitalization until their discharge stage, starting with 3 training sessions for 3 consecutive days. Upon hospital discharge, the technique of inhaler use evaluation will be carried out according to the "Application Steps of Inhalation Techniques Evaluation Form checklist" prepared using the Turkish Thoracic Society Patient's Booklet.

In inhaler technique training observation, inhaler technique control of the patient will be performed simultaneously by 2 observers independently (each observer will have a checklist) to demonstrate inter-observer consistency.

The patients will be called for a control appointment one week after hospital discharge, and their inhaler technique will be recorded once more using the "inhaler technique control form" by the same 2 observers independently.

RANDOMIZATION:

  • ENVELOPE method will be used in randomization.
  • Each clinic will prepare 12 envelopes, 6 of them will have a paper with the words VIRTUAL EDUCATION and 6 of them CLASSIC EDUCATION. The patient will be asked to draw one of these mixed envelopes. The form of education in the envelope will be applied to the patient.

Protocol:

  • Before discharge, the patient should receive a Metered-Dose Inhaler (MDI) training for 3 consecutive days.
  • Classical education (face-to-face education):
  • The person who will provide this training must be a health worker who is an expert in their field.
  • The health personnel who will provide the training should watch the Turkish Thoracic Society MDI training video before giving the training and convey the steps there to the patient (to ensure the patients receive training on an equal basis with the patient who will receive video training).
  • Training should be given 3 times on the first day, 2 times on the 2nd day, and once on the 3rd day.
  • During discharge, inhaler technical evaluation should be done according to the "Application Steps of Inhalation Techniques Evaluation Form checklist" prepared by using the Patient's Booklet of the Turkish Thoracic Society.
  • The people who will evaluate the patient's inhaler technique on the day of discharge should be someone different from the health personnel who provided the training.
  • In inhaler technique observation, the patient's inhaler technique control should be performed simultaneously by 2 observers independently (each observer will have a checklist) to demonstrate inter-observer consistency.

Virtual training (video training):

  • On the first day's training, the video should be watched 3 times a day, on the 2nd day the video should be watched 2 times during the day, on the 3rd day (discharge) the video should be watched once.
  • In video training, the Turkish Thoracic Society Virtual Training Video, (a copy of the video has been provided ), will be used.
  • During discharge, inhaler technical evaluation should be done according to the "Application Steps of Inhalation Techniques Evaluation Form checklist" prepared by using the Patient's Booklet of the Turkish Thoracic Society.
  • The people who will evaluate the patient's inhaler technique on the day of discharge should be someone different from the health personnel who provided the training.
  • In inhaler technique observation, the patient's inhaler technique control should be performed simultaneously by 2 observers independently (each observer will have a checklist) to demonstrate inter-observer consistency.
  • Upon hospital discharge, the patient should be prescribed a short-acting bronchodilator MDI (This is already recommended for all patients in Groups A, B, C, and D according to the GOLD guidelines. In this respect, our study does not fall under a drug study).
  • They should not be advised to watch or not watch the Inhaler Training Video at home (If we allow them to access and watch the video at home, it will create bias). The decision of whether to watch the video at home should be left to the patient (a question will be asked about this at the control. It has been added to the form).
  • The first control after discharge should be done in the 1st week. Patients who cannot come to the hospital for a control appointment due to the pandemic will be called by phone and inhaler techniques will be checked with video conversation. (There is no legal issues as no image recording will be taken here).
Being tested
Treatment training
Medical subject headings
Pulmonary Disease, Chronic Obstructive

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Treatment trainingOther

    Face-to-face:Metered-DoseInhalerTraining gave 3 times on the 1st day, 2 times on the 2nd day, once on the 3rd day.During discharge, inhaler technical evaluation were done according to the "Application Steps of Inhalation Techniques Evaluation Form checklist" prepared by using the Patient's Booklet of the Turkish Thoracic Society (TTS).The people who is evaluate the patient's inhaler technique (IT) on the day of discharge was someone different from the health personnel who provided the training. In IT control, the patient's performance was evaluated simultaneously by 2 observers.

    Video training:Training gave 3 times on the 1st day, 2 times on the 2nd day,once on the 3rd day.The TTS-Virtual Training Video were used.During discharge,inhaler technical evaluation was done same with face-to-face training.The person who is evaluate the patient's IT was someone different from the training personnel.In IT observation,it was used same method with face-to-face training.

Study groups in NCT05335265
Study groupRoleWhat they receive
FIT (face-to-face inhaler training)Active comparatorFace-to-face inhaler training. o The trainers watched the Turkish Thoracic Society (TTS) MDI training video before giving the training. Training given 3 times on the first day, 2 times on the 2nd day, and once on the 3rd day. During discharge, inhaler technic was checked according to the "Application Steps of Inhalation Techniques Evaluation Form checklist" prepared by TTS. The trainer and the inhaler technical controller are different.
Receives: Other: Treatment training
VIT (virtual inhaler training)ExperimentalVirtual Training was gave 3 times on the first day, 2 times on the 2nd day, and once on the 3rd day (discharge) by the TTS Virtual training video. During discharge, inhaler technics of the patient's were controlled according to the "Application Steps of Inhalation Techniques Evaluation Form checklist" prepared by the TTS. o The inhaler technique controller and the trainer are different.
Receives: Other: Treatment training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The success of virtual education

    The primary outcome is to investigate whether video-mediated virtual inhaler training is successful in patients with COPD.

    Measured: 2 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Apr 2022
  2. Study start1 Oct 2021
  3. Primary completion31 Dec 2021
  4. Study completion31 Dec 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Patients randomized according to a simple random numbers table, half of the patients received video-mediated virtual inhaler training (which is published on the Turkish Thoracic Society's official site and with permission for use obtained) and the other half received classical face-to-face inhaler training. "Envelope" method was used in randomization. -Each clinic prepared 12 envelopes, 6 of them have a paper with the words VIRTUAL EDUCATION and 6 of them CLASSIC EDUCATION. The patient was asked to draw one of these mixed envelopes. The form of education in the envelope was applied to the patient.
Masking
None (open label)
Enrolment
102 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05335265
Sponsor's protocol ID
YDU/2021/89-1302
Status last verified
Apr 2022
First submitted
13 Apr 2022
Last updated
28 Apr 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Treatment training in people with COPD and Inhaler Training, run by Ayse Baha at 9 sites in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 9 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The success of virtual education (time frame: 2 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Apr 2022; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in